A detailed history of Voya Investment Management LLC transactions in Heron Therapeutics, Inc. stock. As of the latest transaction made, Voya Investment Management LLC holds 40,233 shares of HRTX stock, worth $65,579. This represents 0.0% of its overall portfolio holdings.

Number of Shares
40,233
Previous 39,557 1.71%
Holding current value
$65,579
Previous $138,000 42.03%
% of portfolio
0.0%
Previous 0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$1.73 - $3.67 $1,169 - $2,480
676 Added 1.71%
40,233 $80,000
Q2 2024

Dec 03, 2024

SELL
$2.32 - $3.86 $1,568 - $2,609
-676 Reduced 1.68%
39,557 $138,000
Q2 2024

Aug 14, 2024

BUY
$2.32 - $3.86 $14,796 - $24,619
6,378 Added 19.22%
39,557 $138,000
Q1 2024

Dec 06, 2024

SELL
$1.71 - $3.06 $12,062 - $21,585
-7,054 Reduced 17.53%
33,179 $91,000
Q1 2024

May 15, 2024

SELL
$1.71 - $3.06 $13,980 - $25,018
-8,176 Reduced 19.77%
33,179 $91,000
Q2 2023

Aug 14, 2023

BUY
$1.11 - $2.88 $2,141 - $5,555
1,929 Added 4.89%
41,355 $47,000
Q2 2022

Aug 15, 2022

BUY
$2.3 - $6.29 $7,249 - $19,826
3,152 Added 8.69%
39,426 $110,000
Q1 2022

May 16, 2022

SELL
$4.63 - $9.94 $1,199 - $2,574
-259 Reduced 0.71%
36,274 $207,000
Q4 2021

Feb 14, 2022

SELL
$8.35 - $12.6 $1.77 Million - $2.67 Million
-211,834 Reduced 85.29%
36,533 $333,000
Q3 2021

Nov 15, 2021

SELL
$10.13 - $15.0 $127,151 - $188,280
-12,552 Reduced 4.81%
248,367 $2.66 Million
Q2 2021

Aug 16, 2021

BUY
$13.27 - $18.48 $476,751 - $663,930
35,927 Added 15.97%
260,919 $4.05 Million
Q1 2021

May 17, 2021

SELL
$14.49 - $20.72 $558,241 - $798,258
-38,526 Reduced 14.62%
224,992 $3.65 Million
Q4 2020

Feb 16, 2021

BUY
$14.61 - $22.14 $3.32 Million - $5.03 Million
227,045 Added 622.5%
263,518 $5.58 Million
Q3 2020

Nov 16, 2020

BUY
$13.67 - $17.77 $21,584 - $28,058
1,579 Added 4.53%
36,473 $541,000
Q2 2020

Aug 14, 2020

SELL
$10.89 - $21.47 $78,789 - $155,335
-7,235 Reduced 17.17%
34,894 $513,000
Q1 2020

May 15, 2020

BUY
$10.23 - $24.56 $10,761 - $25,837
1,052 Added 2.56%
42,129 $495,000
Q4 2019

Feb 14, 2020

BUY
$17.42 - $26.61 $212,088 - $323,976
12,175 Added 42.13%
41,077 $965,000
Q2 2019

Aug 14, 2019

BUY
$16.93 - $26.22 $10,953 - $16,964
647 Added 2.29%
28,902 $537,000
Q4 2018

Feb 14, 2019

BUY
$22.03 - $32.01 $28,264 - $41,068
1,283 Added 4.76%
28,255 $733,000
Q3 2018

Nov 14, 2018

BUY
$30.0 - $40.85 $59,370 - $80,842
1,979 Added 7.92%
26,972 $854,000
Q2 2018

Aug 14, 2018

BUY
$26.4 - $42.0 $78,724 - $125,244
2,982 Added 13.55%
24,993 $971,000
Q1 2018

May 15, 2018

BUY
$18.43 - $28.8 $30,114 - $47,059
1,634 Added 8.02%
22,011 $608,000
Q3 2017

Nov 14, 2017

BUY
$14.65 - $16.85 $298,523 - $343,352
20,377
20,377 $329,000

Others Institutions Holding HRTX

About HERON THERAPEUTICS, INC.


  • Ticker HRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,774,000
  • Market Cap $194M
  • Description
  • Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...
More about HRTX
Track This Portfolio

Track Voya Investment Management LLC Portfolio

Follow Voya Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.